Scioto is a biotechnological company that researches and develops microbiome-based therapeutics to treat brain and bowel diseases... Read more
Scioto is a biotechnological company that researches and develops microbiome-based therapeutics to treat brain and bowel diseases... Read more
News
Apr 03, 2023
Business Wire
Press Release: Scioto Biosciences : Scioto Biosciences Announces Publication of Phase 1b Study in Autism
May 26, 2022
FirstWord Pharma
Scioto Biosciences: Scioto Biosciences, Inc. Announces Top-Line Results of SB-121 in a Phase Ib Trial in Patients Diagnosed With Autism Spectrum Disorder
Aug 18, 2021
MarketScreener
Scioto Biosciences: Scioto Biosciences, Inc. : Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder
Aug 17, 2021
Korea Biomedical Review
Scioto Biosciences: Genome & Company ends 1st dosing of autism treatment in US
Aug 12, 2020
FinSMEs
Scioto Biosciences: Scioto Biosciences Closes Up To $26.5M Strategic Investment
Aug 11, 2020
Inside Indiana Business
Scioto Biosciences: Indy Biosciences Company Completes Major Funding Round
May 15, 2019
4-traders
Scioto Biosciences: Scioto Biosciences : to Present at Microbiome Movement�- Maternal &�Infant�Health Summit in Boston
Nov 05, 2018
PharmiWeb
Scioto Biosciences: Scioto Biosciences Presents Single-dose, Single Strain Pre-clinical C. diff Intervention at American Academy of Pediatrics National Conference & Exhibition
Jun 22, 2018
BioPortfolio
Scioto Biosciences: Scioto Biosciences to Present at Microbiome Movement Drug Development Summit in Boston
May 22, 2018
The Business Journals
Scioto Biosciences: Nationwide Children's spinoff fighting infection in premature babies raises $1.8M
Scioto Biosciences Competitors
1
2
3
4
5
6
7
8
9
10